Fig. 3
p38 MAPK is activated in the lysosome of microglia cells during ischemia-induced SCI. A) Immunoblotting of MEF2D, GAPDH, p-p38α, p38α, p-ATF2 and ATF2 in microgila cells isolated from different groups, and then treated with or without SB203580. Representative blots were from n = 3. B) Densitometric quantification of MEF2D according to immunoblotting, and the calculation of the ratio of p-p38α/p-38α and p-AFT2/AFT based on immunoblotting. n = 3. C) Immunoblotting of p-p38α, p38α, PDI and LAMP1 in the lysosome fractions from microglia cells of different groups. Representative blots were from n = 3. D) The ratio of p-p38α/p38α and PDI/LAMP1 according to immunoblotting. n = 3. *P < 0.05 compared to control and sham; **P < 0.01 compared to control and sham; ***P < 0.001 compared to sham. 2-way ANOVA following Tukey’s multiple comparisons test.

p38 MAPK is activated in the lysosome of microglia cells during ischemia-induced SCI. A) Immunoblotting of MEF2D, GAPDH, p-p38α, p38α, p-ATF2 and ATF2 in microgila cells isolated from different groups, and then treated with or without SB203580. Representative blots were from n = 3. B) Densitometric quantification of MEF2D according to immunoblotting, and the calculation of the ratio of p-p38α/p-38α and p-AFT2/AFT based on immunoblotting. n = 3. C) Immunoblotting of p-p38α, p38α, PDI and LAMP1 in the lysosome fractions from microglia cells of different groups. Representative blots were from n = 3. D) The ratio of p-p38α/p38α and PDI/LAMP1 according to immunoblotting. n = 3. *P < 0.05 compared to control and sham; **P < 0.01 compared to control and sham; ***P < 0.001 compared to sham. 2-way ANOVA following Tukey’s multiple comparisons test.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close